Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus.
暂无分享,去创建一个
D. Mauricio | Marta Roqué i Figuls | B. Richter | B. Hemmingsen | M. Metzendorf | G. Gimenez-Perez | Maria-Inti Metzendorf
[1] M. Riddle,et al. Standards of Medical Care in Diabetes—2020 Abridged for Primary Care Providers , 2019, Clinical Diabetes.
[2] J. Katula,et al. The healthy living partnerships to prevent diabetes and the diabetes prevention program: a comparison of year 1 and 2 intervention results , 2017, Translational behavioral medicine.
[3] L. Delahanty,et al. Self-determination theory and weight loss in a Diabetes Prevention Program translation trial , 2017, Journal of Behavioral Medicine.
[4] K. Thankappan,et al. Baseline characteristics of participants in the Kerala Diabetes Prevention Program: a cluster randomized controlled trial of lifestyle intervention in Asian Indians , 2017, Diabetic medicine : a journal of the British Diabetic Association.
[5] L. Hedges,et al. Basics of meta‐analysis: I2 is not an absolute measure of heterogeneity , 2017, Research synthesis methods.
[6] L. Bero,et al. Industry sponsorship and research outcome. , 2017, The Cochrane database of systematic reviews.
[7] K. Khunti,et al. A community-based primary prevention programme for type 2 diabetes mellitus integrating identification and lifestyle intervention for prevention: a cluster randomised controlled trial , 2017 .
[8] K. Khunti,et al. Cost-effectiveness of a pragmatic structured education intervention for the prevention of type 2 diabetes: economic evaluation of data from the Let's Prevent Diabetes cluster-randomised controlled trial , 2017, BMJ Open.
[9] James Woodcock,et al. Physical activity and incident type 2 diabetes mellitus: a systematic review and dose–response meta-analysis of prospective cohort studies , 2016, Diabetologia.
[10] B. Richter,et al. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus. , 2016, The Cochrane database of systematic reviews.
[11] U. Lindblad,et al. A lifestyle intervention in primary care prevents deterioration of insulin resistance in patients with impaired glucose tolerance: A randomised controlled trial , 2016, Scandinavian journal of public health.
[12] M. Engelgau,et al. Changes in Mortality in People With IGT Before and After the Onset of Diabetes During the 23-Year Follow-up of the Da Qing Diabetes Prevention Study , 2016, Diabetes Care.
[13] K. Khunti,et al. Engagement, Retention, and Progression to Type 2 Diabetes: A Retrospective Analysis of the Cluster-Randomised "Let's Prevent Diabetes" Trial , 2016, PLoS medicine.
[14] N. Lv,et al. Evaluation of a culturally-adapted lifestyle intervention to treat elevated cardiometabolic risk of Latino adults in primary care (Vida Sana): A randomized controlled trial. , 2016, Contemporary clinical trials.
[15] D. Marrero,et al. Comparison of Commercial and Self-Initiated Weight Loss Programs in People With Prediabetes: A Randomized Control Trial. , 2016, American journal of public health.
[16] Y. Ma,et al. Comparison of control fasting plasma glucose of exercise-only versus exercise-diet among a pre-diabetic population: a meta-analysis , 2016, European Journal of Clinical Nutrition.
[17] P. Modesti,et al. Lifestyle interventions in preventing new type 2 diabetes in Asian populations , 2016, Internal and Emergency Medicine.
[18] B. Duncan,et al. Lifestyle INtervention for Diabetes prevention After pregnancy (LINDA-Brasil): study protocol for a multicenter randomized controlled trial , 2016, BMC Pregnancy and Childbirth.
[19] K. Khunti,et al. A community based primary prevention programme for type 2 diabetes integrating identification and lifestyle intervention for prevention: the Let's Prevent Diabetes cluster randomised controlled trial. , 2016, Preventive medicine.
[20] M. Kivipelto,et al. Association of long-term dietary fat intake, exercise, and weight with later cognitive function in the Finnish Diabetes Prevention Study , 2016, The journal of nutrition, health & aging.
[21] A. Sheikh,et al. Associations between weight change and biomarkers of cardiometabolic risk in South Asians: secondary analyses of the PODOSA Trial , 2016, International Journal of Obesity.
[22] M. Kivipelto,et al. Diabetes, glycaemia, and cognition—a secondary analysis of the Finnish Diabetes Prevention Study , 2016, Diabetes/metabolism research and reviews.
[23] K. Khunti,et al. A Text-Messaging and Pedometer Program to Promote Physical Activity in People at High Risk of Type 2 Diabetes: The Development of the PROPELS Follow-On Support Program , 2015, JMIR mHealth and uHealth.
[24] K. Jablonski,et al. Lifestyle and Metformin Ameliorate Insulin Sensitivity Independently of the Genetic Burden of Established Insulin Resistance Variants in Diabetes Prevention Program Participants , 2015, Diabetes.
[25] K. Kotani,et al. Effects of lifestyle intervention on weight and metabolic parameters in patients with impaired glucose tolerance related to beta‐3 adrenergic receptor gene polymorphism Trp64Arg(C/T): Results from the Japan Diabetes Prevention Program , 2015, Journal of diabetes investigation.
[26] Jia Liu,et al. [Effects of lifestyle and quantitative nutrition interventions on individuals with prediabetes]. , 2015, Zhonghua yi xue za zhi.
[27] P. Remington,et al. Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force , 2015, Annals of Internal Medicine.
[28] E. Barrett-Connor,et al. Long-term Effects of Lifestyle Intervention or Metformin on Diabetes Development and Microvascular Complications: the DPP Outcomes Study , 2015, The lancet. Diabetes & endocrinology.
[29] W. Herman. The cost-effectiveness of diabetes prevention: results from the Diabetes Prevention Program and the Diabetes Prevention Program Outcomes Study , 2015, Clinical Diabetes and Endocrinology.
[30] Ronald T Ackermann,et al. The comparative efficacy of lifestyle intervention and metformin by educational attainment in the Diabetes Prevention Program. , 2015, Preventive medicine.
[31] K. Khunti,et al. PRomotion Of Physical activity through structured Education with differing Levels of ongoing Support for people at high risk of type 2 diabetes (PROPELS): study protocol for a randomized controlled trial , 2015, Trials.
[32] J. Eriksson,et al. Markers of cholesterol metabolism as biomarkers in predicting diabetes in the Finnish Diabetes Prevention Study. , 2015, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[33] M. Kivipelto,et al. Cognition in the Finnish diabetes prevention study. , 2015, Diabetes research and clinical practice.
[34] S. Selph,et al. Screening for Abnormal Glucose and Type 2 Diabetes Mellitus: A Systematic Review to Update the 2008 U.S. Preventive Services Task Force Recommendation , 2015 .
[35] K. Khunti,et al. Preventing the progression to type 2 diabetes mellitus in adults at high risk: a systematic review and network meta-analysis of lifestyle, pharmacological and surgical interventions. , 2015, Diabetes research and clinical practice.
[36] E. Barrett-Connor,et al. The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up. , 2015, The Journal of clinical endocrinology and metabolism.
[37] E. Vittinghoff,et al. Long‐term prevalence and predictors of urinary incontinence among women in the Diabetes Prevention Program Outcomes Study , 2015, International journal of urology : official journal of the Japanese Urological Association.
[38] J. Tuomilehto,et al. Sex-specific differences in diabetes prevention: a systematic review and meta-analysis , 2015, Diabetologia.
[39] C. Snehalatha,et al. Improvement in diet habits, independent of physical activity helps to reduce incident diabetes among prediabetic Asian Indian men. , 2014, Diabetes research and clinical practice.
[40] A. Kriska,et al. Long‐term changes in dietary and food intake behaviour in the Diabetes Prevention Program Outcomes Study , 2014, Diabetic medicine : a journal of the British Diabetic Association.
[41] S. Fowler,et al. HbA1c as a Predictor of Diabetes and as an Outcome in the Diabetes Prevention Program: A Randomized Clinical Trial , 2014, Diabetes Care.
[42] Ambady Ramachandran,et al. Early Improvement Predicts Reduced Risk of Incident Diabetes and Improved Cardiovascular Risk in Prediabetic Asian Indian Men Participating in a 2-Year Lifestyle Intervention Program , 2014, Diabetes Care.
[43] G. Bray,et al. Factors Affecting the Decline in Incidence of Diabetes in the Diabetes Prevention Program Outcomes Study (DPPOS) , 2014, Diabetes.
[44] A. Gosmanov,et al. Low Positive Predictive Value of Hemoglobin A1c for Diagnosis of Prediabetes in Clinical Practice , 2014, The American journal of the medical sciences.
[45] A. Morabito,et al. Prevention of type 2 diabetes in obese at-risk subjects: a systematic review and meta-analysis , 2014, Acta Diabetologica.
[46] A. Morabito,et al. Prevention of type 2 diabetes; a systematic review and meta‐analysis of different intervention strategies , 2014, Diabetes, obesity & metabolism.
[47] N. Meader,et al. A checklist designed to aid consistency and reproducibility of GRADE assessments: development and pilot validation , 2014, Systematic Reviews.
[48] R. Wheeler,et al. The epidemic of pre-diabetes: the medicine and the politics , 2014, BDJ.
[49] K. Watson,et al. Lifestyle and Metformin Interventions Have a Durable Effect to Lower CRP and tPA Levels in the Diabetes Prevention Program Except in Those Who Develop Diabetes , 2014, Diabetes Care.
[50] G. Roglić,et al. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. , 2014, The lancet. Diabetes & endocrinology.
[51] U. Lindblad,et al. Feasibility of a randomized controlled intervention with physical activity in participants with impaired glucose tolerance recruited by FINDRISC: A pilot study , 2014, Scandinavian journal of public health.
[52] K. Kotani,et al. Effect of baseline HbA1c level on the development of diabetes by lifestyle intervention in primary healthcare settings: insights from subanalysis of the Japan Diabetes Prevention Program , 2014, BMJ Open Diabetes Research and Care.
[53] E. Barrett-Connor,et al. Metabolic syndrome components and their response to lifestyle and metformin interventions are associated with differences in diabetes risk in persons with impaired glucose tolerance , 2014, Diabetes, obesity & metabolism.
[54] K. Khunti,et al. Diabetes Prevention in the Real World: Effectiveness of Pragmatic Lifestyle Interventions for the Prevention of Type 2 Diabetes and of the Impact of Adherence to Guideline Recommendations , 2014, Diabetes Care.
[55] Anne Douglas,et al. Effect of a lifestyle intervention on weight change in south Asian individuals in the UK at high risk of type 2 diabetes: a family-cluster randomised controlled trial. , 2014, The lancet. Diabetes & endocrinology.
[56] E. Barrett-Connor,et al. Impact of diagnosis of diabetes on health-related quality of life among high risk individuals: the Diabetes Prevention Program outcomes study , 2014, Quality of Life Research.
[57] Elroy J. Aguiar,et al. Efficacy of interventions that include diet, aerobic and resistance training components for type 2 diabetes prevention: a systematic review with meta-analysis , 2014, International Journal of Behavioral Nutrition and Physical Activity.
[58] H. Bilo,et al. A cluster-randomized controlled trial to study the effectiveness of a protocol-based lifestyle program to prevent type 2 diabetes in people with impaired fasting glucose , 2013, BMC Family Practice.
[59] K. W. Wong,et al. A short message service (SMS) intervention to prevent diabetes in Chinese professional drivers with pre-diabetes: a pilot single-blinded randomized controlled trial. , 2013, Diabetes research and clinical practice.
[60] C. Toumazou,et al. Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India: a prospective, parallel-group, randomised controlled trial. , 2013, The lancet. Diabetes & endocrinology.
[61] B. Vandermeer,et al. Lifestyle Interventions for Patients With and at Risk for Type 2 Diabetes , 2013, Annals of Internal Medicine.
[62] J. McKenzie,et al. Designing psycho‐oncology randomised trials and cluster randomised trials: variance components and intra‐cluster correlation of commonly used psychosocial measures , 2013, Psycho-oncology.
[63] K. Khunti,et al. Progression rates from HbA1c 6.0–6.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis , 2013, Diabetologia.
[64] J. Katula,et al. Cost of a group translation of the Diabetes Prevention Program: Healthy Living Partnerships to Prevent Diabetes. , 2013, American journal of preventive medicine.
[65] Morton B. Brown,et al. Effectiveness and cost-effectiveness of diabetes prevention among adherent participants. , 2013, The American journal of managed care.
[66] J. Hilden,et al. Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors , 2013, Canadian Medical Association Journal.
[67] E. Feskens,et al. Importance of Weight Loss Maintenance and Risk Prediction in the Prevention of Type 2 Diabetes: Analysis of European Diabetes Prevention Study RCT , 2013, PloS one.
[68] J. Forbes,et al. Design and baseline characteristics of the PODOSA (Prevention of Diabetes & Obesity in South Asians) trial: a cluster, randomised lifestyle intervention in Indian and Pakistani adults with impaired glycaemia at high risk of developing type 2 diabetes , 2013, BMJ Open.
[69] S. Aunola,et al. Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS) , 2013, Diabetologia.
[70] K. Kotani,et al. Japan Diabetes Outcome Intervention Trial-1(J-DOIT1), a nationwide cluster randomized trial of type 2 diabetes prevention by telephone-delivered lifestyle support for high-risk subjects detected at health checkups: rationale, design, and recruitment , 2013, BMC Public Health.
[71] S. Inzucchi. Clinical practice. Diagnosis of diabetes. , 2012, New England Journal of Medicine.
[72] A. Brennan,et al. Non-pharmacological interventions to reduce the risk of diabetes in people with impaired glucose regulation: a systematic review and economic evaluation. , 2012, Health technology assessment.
[73] A. Kriska,et al. Impact of Lifestyle Intervention and Metformin on Health-Related Quality of Life: the Diabetes Prevention Program Randomized Trial , 2012, Journal of General Internal Medicine.
[74] U. Yoon,et al. Efficacy of lifestyle interventions in reducing diabetes incidence in patients with impaired glucose tolerance: a systematic review of randomized controlled trials , 2012, BMC Proceedings.
[75] K. Khunti,et al. Walking away from type 2 diabetes: trial protocol of a cluster randomised controlled trial evaluating a structured education programme in those at high risk of developing type 2 diabetes , 2012, BMC Family Practice.
[76] K. Stronks,et al. Feasibility and effectiveness of a targeted diabetes prevention program for 18 to 60-year-old South Asian migrants: design and methods of the DH!AAN study , 2012, BMC Public Health.
[77] K. Khunti,et al. Let’s prevent diabetes: study protocol for a cluster randomised controlled trial of an educational intervention in a multi-ethnic UK population with screen detected impaired glucose regulation , 2012, Cardiovascular Diabetology.
[78] V. Mohan,et al. A model of translational research for diabetes prevention in low and middle-income countries: The Diabetes Community Lifestyle Improvement Program (D-CLIP) trial. , 2012, Primary care diabetes.
[79] Ping Zhang,et al. The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention , 2012, Diabetes Care.
[80] G. Bray,et al. Long-Term Safety, Tolerability, and Weight Loss Associated With Metformin in the Diabetes Prevention Program Outcomes Study , 2012, Diabetes Care.
[81] K. Khunti,et al. The Pre‐diabetes Risk Education and Physical Activity Recommendation and Encouragement (PREPARE) programme study: are improvements in glucose regulation sustained at 2 years? , 2011, Diabetic medicine : a journal of the British Diabetic Association.
[82] B. Billah,et al. Prevention of diabetes and reduction in major cardiovascular events in studies of subjects with prediabetes: meta-analysis of randomised controlled clinical trials , 2011, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[83] Makoto Watanabe,et al. Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose levels: a randomized controlled trial. , 2011, Archives of internal medicine.
[84] J. Ioannidis,et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials , 2011, BMJ : British Medical Journal.
[85] J. Katula,et al. One-Year Results of a Community-Based Translation of the Diabetes Prevention Program , 2011, Diabetes Care.
[86] A. Viera. Predisease: when does it make sense? , 2011, Epidemiologic reviews.
[87] Elizabeth Selvin,et al. Racial Differences in Glycemic Markers: A Cross-sectional Analysis of Community-Based Data , 2011, Annals of Internal Medicine.
[88] Richard D Riley,et al. Interpretation of random effects meta-analyses , 2011, BMJ : British Medical Journal.
[89] J. Zhang,et al. Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study , 2011, Diabetologia.
[90] K. Kotani,et al. Prevention of type 2 diabetes in a primary healthcare setting: Three-year results of lifestyle intervention in Japanese subjects with impaired glucose tolerance , 2011, BMC public health.
[91] P. O S I T I O N S T A T E M E N T,et al. Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.
[92] Anne Whitehead,et al. Sequential methods for random-effects meta-analysis , 2010, Statistics in medicine.
[93] Magnolia Cardona-Morrell,et al. Reduction of diabetes risk in routine clinical practice: are physical activity and nutrition interventions feasible and are the outcomes from reference trials replicable? A systematic review and meta-analysis , 2010, BMC public health.
[94] N. Tong,et al. Metformin for people with impaired glucose tolerance or impaired fasting blood glucose , 2010 .
[95] Ambady Ramachandran,et al. Efficacy of Primary Prevention Interventions When Fasting and Postglucose Dysglycemia Coexist , 2010, Diabetes Care.
[96] P. Vermunt,et al. An active strategy to identify individuals eligible for type 2 diabetes prevention by lifestyle intervention in Dutch primary care: the APHRODITE study. , 2010, Family practice.
[97] T. Weiland,et al. Lifestyle and medication interventions for the prevention or delay of type 2 diabetes mellitus in prediabetes: a systematic review of randomised controlled trials , 2010, Australian and New Zealand journal of public health.
[98] Douglas G Altman,et al. The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews , 2010, BMJ : British Medical Journal.
[99] E. Ross. Reflections on slow manuscript reviews , 2009, The Lancet.
[100] David M Nathan,et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. , 2009, Lancet.
[101] M. Walker,et al. Prevention of type 2 diabetes in adults with impaired glucose tolerance: the European Diabetes Prevention RCT in Newcastle upon Tyne, UK , 2009, BMC public health.
[102] David Moher,et al. Comparison of registered and published primary outcomes in randomized controlled trials. , 2009, JAMA.
[103] Ambady Ramachandran,et al. Changes in Insulin Secretion and Insulin Sensitivity in Relation to the Glycemic Outcomes in Subjects With Impaired Glucose Tolerance in the Indian Diabetes Prevention Programme-1 (IDPP-1) , 2009, Diabetes Care.
[104] J. Shaw,et al. International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes , 2009, Diabetes Care.
[105] J. Ioannidis,et al. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration , 2009, BMJ : British Medical Journal.
[106] T. Vos,et al. Cost-Effectiveness of Interventions to Promote Physical Activity: A Modelling Study , 2009, PLoS medicine.
[107] T. Valle,et al. Ten-Year Mortality and Cardiovascular Morbidity in the Finnish Diabetes Prevention Study—Secondary Analysis of the Randomized Trial , 2009, PloS one.
[108] Kristian Thorlund,et al. Apparently conclusive meta-analyses may be inconclusive--Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses. , 2009, International journal of epidemiology.
[109] K. Borch-Johnsen,et al. A randomized lifestyle intervention with 5-year follow-up in subjects with impaired glucose tolerance: Pronounced short-term impact but long-term adherence problems , 2009, Scandinavian journal of public health.
[110] David J Spiegelhalter,et al. A re-evaluation of random-effects meta-analysis , 2009, Journal of the Royal Statistical Society. Series A,.
[111] Jaakko Tuomilehto,et al. Determinants for the Effectiveness of Lifestyle Intervention in the Finnish Diabetes Prevention Study , 2008, Diabetes Care.
[112] Yoshiya Tanaka,et al. Reduced Progression to Type 2 Diabetes From Impaired Glucose Tolerance After a 2-Day In-Hospital Diabetes Educational Program , 2008, Diabetes Care.
[113] Douglas G. Altman,et al. Chapter 9: Analysing Data and Undertaking Meta-Analyses , 2008 .
[114] D. Altman,et al. Chapter 8: Assessing risk of bias in included studies , 2008 .
[115] A. Oxman,et al. Outcomes of patients who participate in randomized controlled trials compared to similar patients receiving similar interventions who do not participate. , 2008, The Cochrane database of systematic reviews.
[116] Bernd Richter,et al. Exercise or exercise and diet for preventing type 2 diabetes mellitus. , 2008, The Cochrane database of systematic reviews.
[117] M. White,et al. Participants' perspective on maintaining behaviour change: a qualitative study within the European Diabetes Prevention Study , 2008, BMC public health.
[118] E. Barrett-Connor,et al. Sex Differences in Diabetes Risk and the Effect of Intensive Lifestyle Modification in the Diabetes Prevention Program , 2008, Diabetes Care.
[119] D. West,et al. Weight Loss of Black, White, and Hispanic Men and Women in the Diabetes Prevention Program , 2008, Obesity.
[120] Bo Zhang,et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study , 2008, The Lancet.
[121] W. Saris,et al. Impact of 3‐year lifestyle intervention on postprandial glucose metabolism: the SLIM study , 2008, Diabetic medicine : a journal of the British Diabetic Association.
[122] Douglas G Altman,et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study , 2008, BMJ : British Medical Journal.
[123] C. Qualls,et al. Reducing diabetes risk in American Indian women. , 2008, American journal of preventive medicine.
[124] C. Snehalatha,et al. Beneficial effects of strategies for primary prevention of diabetes on cardiovascular risk factors: results of the Indian Diabetes Prevention Programme , 2008, Diabetes & vascular disease research.
[125] Stephen Sutton,et al. Efficacy of a theory-based behavioural intervention to increase physical activity in an at-risk group in primary care (ProActive UK): a randomised trial , 2008, The Lancet.
[126] M. Cassader,et al. Effectiveness of a Lifestyle Intervention on Metabolic Syndrome. A Randomized Controlled Trial , 2007, Journal of General Internal Medicine.
[127] Ambady Ramachandran,et al. Cost-Effectiveness of the Interventions in the Primary Prevention of Diabetes Among Asian Indians , 2007, Diabetes Care.
[128] E. Feskens,et al. Lifestyle Intervention and Adipokine Levels in Subjects at High Risk for Type 2 Diabetes , 2007, Diabetes Care.
[129] K. Weng,et al. Effects of a classroom-based weight-control intervention on cardiovascular disease in elementary-school obese children. , 2007, Acta paediatrica Taiwanica = Taiwan er ke yi xue hui za zhi.
[130] Sonia Caprio,et al. Effects of a weight management program on body composition and metabolic parameters in overweight children: a randomized controlled trial. , 2007, JAMA.
[131] Ambady Ramachandran,et al. Metabolic syndrome does not increase the risk of conversion of impaired glucose tolerance to diabetes in Asian Indians--Result of Indian diabetes prevention programme. , 2007, Diabetes research and clinical practice.
[132] K. Khunti,et al. The role of physical activity in the management of impaired glucose tolerance: a systematic review , 2007, Diabetologia.
[133] Nicola J Cooper,et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis , 2007, BMJ : British Medical Journal.
[134] S. Klein,et al. Effect of lifestyle intervention on metabolic coronary heart disease risk factors in obese older adults. , 2006, The American journal of clinical nutrition.
[135] J. Lindström,et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study , 2006, The Lancet.
[136] R. Haynes,et al. Comparison of top-performing search strategies for detecting clinically sound treatment studies and systematic reviews in MEDLINE and EMBASE. , 2006, Journal of the Medical Library Association : JMLA.
[137] S. Fowler,et al. The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.
[138] M. Eliasson,et al. A randomized trial of lifestyle intervention in primary healthcare for the modification of cardiovascular risk factors The Björknäs study , 2006, Scandinavian journal of public health.
[139] E. Feskens,et al. Improvements in glucose tolerance and insulin sensitivity after lifestyle intervention are related to changes in serum fatty acid profile and desaturase activities: the SLIM study , 2006, Diabetologia.
[140] T. Valle,et al. Systemic Immune Mediators and Lifestyle Changes in the Prevention of Type 2 Diabetes , 2006, Diabetes.
[141] K. Alberti,et al. Randomised controlled trial evaluating lifestyle interventions in people with impaired glucose tolerance. , 2006, Diabetes research and clinical practice.
[142] R. DeFronzo,et al. Insulin Secretion and Action in Subjects With Impaired Fasting Glucose and Impaired Glucose Tolerance , 2006, Diabetes.
[143] B. Falkner,et al. The utility of fasting glucose for detection of prediabetes. , 2006, Metabolism: clinical and experimental.
[144] J. Eriksson,et al. High-fibre, low-fat diet predicts long-term weight loss and decreased type 2 diabetes risk: the Finnish Diabetes Prevention Study , 2006, Diabetologia.
[145] N. Clark,et al. Standards of Medical Care in Diabetes: Response to Power , 2006 .
[146] C. Snehalatha,et al. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1) , 2006, Diabetologia.
[147] Toshiro Tango,et al. Efficacy of lifestyle education to prevent type 2 diabetes: a meta-analysis of randomized controlled trials. , 2005, Diabetes care.
[148] T. Valle,et al. Improved fibrinolysis by an intensive lifestyle intervention in subjects with impaired glucose tolerance. The Finnish Diabetes Prevention Study , 2005, Diabetologia.
[149] P. Raina,et al. Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose. , 2005, Evidence report/technology assessment.
[150] S. Fowler,et al. Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance. , 2005, Diabetes.
[151] C. Schmid,et al. Long-term non-pharmacological weight loss interventions for adults with prediabetes. , 2005, The Cochrane database of systematic reviews.
[152] S. Fowler,et al. Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program. , 2005, Diabetes care.
[153] R. Schwartz,et al. A reduced-fat diet and aerobic exercise in Japanese Americans with impaired glucose tolerance decreases intra-abdominal fat and improves insulin sensitivity but not beta-cell function. , 2005, Diabetes.
[154] K. Kosaka,et al. Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. , 2005, Diabetes research and clinical practice.
[155] N. Sakane. [Japan Diabetes Prevention Program]. , 2005, Nihon rinsho. Japanese journal of clinical medicine.
[156] J. Chiasson,et al. Prevention of type 2 diabetes: insulin resistance and beta-cell function. , 2004, Diabetes.
[157] Judith Wylie-Rosett,et al. Achieving weight and activity goals among diabetes prevention program lifestyle participants. , 2004, Obesity research.
[158] G. Melkus,et al. Preliminary testing of a program to prevent type 2 diabetes among high-risk youth. , 2004, The Journal of school health.
[159] Jaakko Tuomilehto,et al. The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. , 2003, Diabetes care.
[160] E. Feskens,et al. Lifestyle intervention according to general recommendations improves glucose tolerance. , 2003, Obesity research.
[161] J. Shaw,et al. Follow-up report on the diagnosis of diabetes mellitus. , 2003, Diabetes care.
[162] J. Tuomilehto,et al. Long-term improvement in insulin sensitivity by changing lifestyles of people with impaired glucose tolerance: 4-year results from the Finnish Diabetes Prevention Study. , 2003, Diabetes.
[163] D. Altman,et al. Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.
[164] E. Feskens,et al. Subscapular skinfold thickness distinguishes between transient and persistent impaired glucose tolerance: Study on Lifestyle‐Intervention and Impaired Glucose Tolerance Maastricht (SLIM) , 2003, Diabetic medicine : a journal of the British Diabetic Association.
[165] T. Valle,et al. Prevention of diabetes mellitus in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study: results from a randomized clinical trial. , 2003, Journal of the American Society of Nephrology : JASN.
[166] E. Feskens,et al. Study on lifestyle-intervention and impaired glucose tolerance Maastricht (SLIM): design and screening results. , 2003, Diabetes research and clinical practice.
[167] B. Howard,et al. Effects of insulin resistance and insulin secretion on the efficacy of interventions to retard development of type 2 diabetes mellitus: the DA Qing IGT and Diabetes Study. , 2002, Diabetes research and clinical practice.
[168] R. Schwartz,et al. Improvement of BMI, body composition, and body fat distribution with lifestyle modification in Japanese Americans with impaired glucose tolerance. , 2002, Diabetes care.
[169] S. Thompson,et al. Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.
[170] E. Fisher,et al. The Diabetes Prevention Program: recruitment methods and results. , 2002, Controlled clinical trials.
[171] S. Fowler,et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002, The New England journal of medicine.
[172] T. Valle,et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.
[173] K. Alberti,et al. Randomised controlled trial evaluating the effectiveness of behavioural interventions to modify cardiovascular risk factors in men and women with impaired glucose tolerance: outcomes at 6 months. , 2001, Diabetes research and clinical practice.
[174] T. Valle,et al. The Finnish Diabetes Prevention Study , 2000, British Journal of Nutrition.
[175] G. Hallmans,et al. Improved fibrinolysis by intense lifestyle intervention. A randomized trial in subjects with impaired glucose tolerance , 1999, Journal of internal medicine.
[176] T. Valle,et al. Prevention of Type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland Study design and 1-year interim report on the feasibility of the lifestyle intervention programme , 1999, Diabetologia.
[177] M. Permezel,et al. A Trial of Simple versus Intensified Dietary Modification for Prevention of Progression to Diabetes Mellitus in Women with Impaired Glucose Tolerance , 1999, The Australian & New Zealand journal of obstetrics & gynaecology.
[178] P. Raskin,et al. Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.
[179] P. Zimmet,et al. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.
[180] R. Wing,et al. Lifestyle Intervention in Overweight Individuals With a Family History of Diabetes , 1998, Diabetes Care.
[181] R. Holman,et al. The Fasting Hyperglycaemia Study: III. Randomized controlled trial of sulfonylurea therapy in subjects with increased but not diabetic fasting plasma glucose. , 1997, Metabolism: clinical and experimental.
[182] R. Holman,et al. The Fasting Hyperglycaemia Study: II. Randomized controlled trial of reinforced healthy-living advice in subjects with increased but not diabetic fasting plasma glucose. , 1997, Metabolism: clinical and experimental.
[183] R. Holman,et al. The Fasting Hyperglycaemia Study: I. Subject identification and recruitment for a non-insulin-dependent diabetes prevention trial. , 1997, Metabolism: clinical and experimental.
[184] S. Yusuf,et al. Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta-analysis. , 1997, Controlled clinical trials.
[185] R. Hayward,et al. Estimated Benefits of Glycemic Control in Microvascular Complications in Type 2 Diabetes , 1997, Annals of Internal Medicine.
[186] B. Howard,et al. Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes Study , 1997, Diabetes Care.
[187] J. Levy,et al. 'Healthy living' and sulphonylurea therapy have different effects on glucose tolerance and risk factors for vascular disease in subjects with impaired glucose tolerance. , 1993, The Quarterly journal of medicine.
[188] W C Willett,et al. A prospective study of exercise and incidence of diabetes among US male physicians. , 1992, JAMA.
[189] R. Turner,et al. Can Life‐styles of Subjects With Impaired Glucose Tolerance Be Changed? A Feasibility Study , 1992, Diabetic medicine : a journal of the British Diabetic Association.
[190] K. Eriksson,et al. Prevention of Type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise The 6-year Malmö feasibility study , 1991, Diabetologia.
[191] R. Paffenbarger,et al. Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. , 1991, The New England journal of medicine.
[192] R. DeFronzo,et al. Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. , 1989, Metabolism: clinical and experimental.
[193] K. K. Lan,et al. Discrete sequential boundaries for clinical trials , 1983 .
[194] G. Sartor,et al. Ten-year Follow-up of Subjects with Impaired Glucose Tolerance: Prevention of Diabetes by Tolbutamide and Diet Regulation , 1980, Diabetes.
[195] F. Lobelo,et al. Effect of lifestyle interventions on glucose regulation among adults without impaired glucose tolerance or diabetes: A systematic review and meta-analysis. , 2017, Diabetes research and clinical practice.
[196] Wenying Yang,et al. [Effect of lifestyle interventions on reduction of cardiovascular disease events and its mortality in pre-diabetic patients:long-term follow-up of Da Qing Diabetes Prevention Study]. , 2015, Zhonghua nei ke za zhi.
[197] Hui Li,et al. Lifestyle interventions for adults with impaired glucose tolerance: a systematic review and meta-analysis of the effects on glycemic control. , 2015, Internal medicine.
[198] G. Bray,et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. , 2013, The New England journal of medicine.
[199] D. Williamson,et al. How effective were lifestyle interventions in real-world settings that were modeled on the Diabetes Prevention Program? , 2012, Health affairs.
[200] J. Katula,et al. Healthy Living Partnerships to Prevent Diabetes: recruitment and baseline characteristics. , 2011, Contemporary clinical trials.
[201] E. Feskens,et al. Predictors of lifestyle intervention outcome and dropout: the SLIM study , 2011, European Journal of Clinical Nutrition.
[202] M. Espeland,et al. Healthy Living Partnerships to Prevent Diabetes (HELP PD): design and methods. , 2010, Contemporary clinical trials.
[203] BMC Family Practice BioMed Central Study protocol , 2009 .
[204] K. Thorlund,et al. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. , 2008, Journal of clinical epidemiology.
[205] R Brian Haynes,et al. Developing optimal search strategies for detecting clinically sound treatment studies in EMBASE. , 2006, Journal of the Medical Library Association : JMLA.
[206] Zygimantas Cepaitis,et al. Physical activity in the prevention of type 2 diabetes: the Finnish diabetes prevention study. , 2005, Diabetes.
[207] H. Keen,et al. Worsening to diabetes in men with impaired glucose tolerance (“borderline diabetes”) , 2004, Diabetologia.
[208] E. Feskens,et al. Study on Lifestyle Intervention and Impaired Glucose Tolerance Maastricht (SLIM): preliminary results after one year , 2003, International Journal of Obesity.
[209] Ping Zhang,et al. Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program. , 2003, Diabetes care.
[210] C. Champagne,et al. The Diabetes Prevention Program: baseline characteristics of the randomized cohort. The Diabetes Prevention Program Research Group. , 2000, Diabetes care.
[211] Melvin Prince,et al. The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes. , 1999, Diabetes care.